Synoptophor
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
26-05-2019
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Device Technologies Australia Pty Ltd
Class:
Class Im
Manufactured by:
Haag Streit UK Ltd Edinburgh Way, Harlow, Essex, CM20 2TT United Kingdom
Therapeutic area:
36058 - Synoptophor
Therapeutic indications:
Used in the diagnosis and treatment of ophthalmic function including assessment of the angle alpha, objective angle, abnormal retina corespondence, eccentric fixation, cyclophoria, hyperphoria and vergences.
Authorization status:
A
Authorization date:
2003-12-15
